AngioDynamics Inc at UBS Global Healthcare Conference Transcript
Hi. Well, look, thank you, everyone, for joining us today. I think, at least for me, this is the last session of the day. And I couldn't be happier to be sitting here next to these 2 gentlemen.
So I'm Seth Damergy, I lead the medical device investment banking practice at UBS. And I'm pleased to be able to introduce our next presenters or more of our fireside chat, AngioDynamics. So we have Jim Clemmer, CEO; Steve Trowbridge, CFO of the company. Two folks I've known for a very long period of time.
AngioDynamics is a NASDAQ-listed med tech company. We'll go through some Q&A. I've got an iPad up here that's going to have lots of your questions. But in the meantime, I'll get the Q&A started. So feel free to just jump in with anything that you feel is pertinent.
Questions & Answers
So gentlemen, I thought it would make sense, with everything that we're seeing in the market and even what we've heard from you about some of the macro dynamics. To start off with inflation. So from an inflation perspective, how do you see
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
